en · de · es · fr · pt
cjc-1295-notes.peptides1004.com › Faq › Albumin Binding And Duration Of Action — 2026 Update

Albumin Binding And Duration Of Action — 2026 Update

By Editorial Desk · published 2026-06-01 · last reviewed 2026-07-16 · Faq

If you have been reading about GHRH receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-07-16. Numbers and descriptions here follow the published literature rather than marketing material.

Albumin Binding and Duration of Action

Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.

The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.

Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.

Receptor Action and Clearance

Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Cjc-1295 at a glance

PropertyValueNotes
Duration with linkerSeveral daysReported in early human work
Duration without linkerTens of minutesShort plasma residence
Albumin attachment siteCysteine-34Covalent maleimide reaction
Primary receptorPituitary GHRH receptorStimulates growth hormone release
Downstream markerInsulin-like growth factor 1Indirect measure of activity

Background and Molecular Design

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Related pages on this site

Handling, Stability and Analysis

Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.

Background and Receptor Mechanism

CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.

Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.

At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.

Reference notes

India remained a member of the Commonwealth of Nations after becoming a republic in 1950. It strongly supported decolonisation in Africa and Asia in the 1950s, and played a leading role in the Non-Aligned Movement. Following a period of cordial relations in the 1950s, India and China went to war in 1962, resulting in a decisive military defeat for India. By 1967, however, India was able to fend off Chinese excursions into Sikkim. India has had uneasy relations with its western neighbour, Pakistan. The two went to war in 1947, 1965, 1971, and 1999. Three wars were fought over the disputed territory of Kashmir. After the 1965 war, India began to pursue close military and economic ties with the Soviet Union. By the late 1960s, the Soviet Union was India's largest arms supplier. China's nuclear test of 1964 and threats to intervene in support of Pakistan in the 1965 war caused India to produce nuclear weapons. India conducted its first nuclear weapons test in 1974 and carried out additional underground testing in 1998. India has signed neither the Comprehensive Nuclear-Test-Ban Treaty nor the Nuclear Non-Proliferation Treaty, calling both flawed and discriminatory. India maintains a "no first use" nuclear policy and possesses a nuclear triad as a part of its "Minimum Credible Deterrence" doctrine. Since the end of the Cold War, India has increased its economic, strategic, and military cooperation with the United States and the European Union. In 2008, a civilian nuclear agreement was signed between India and the United States.

== Induced regeneration == There are several human tissues that have been successfully or partially induced to regenerate. Many fall under the topic of regenerative medicine, which includes the methods and research conducted with the aim of regenerating the organs and tissues of humans as a result of injury. The major strategies of regenerative medicine include dedifferentiating injury site cells, transplanting stem cells, implanting lab-grown tissues and organs, and implanting bioartificial tissues.

A raw egg is mixed with a bowl of Japanese rice. The rice can be cold, freshly cooked, or reheated. The egg may be broken directly into the rice bowl (either before or after the rice is added), or beaten in a separate bowl beforehand. Some people make a well in the mound of rice to pour the egg into. Variations on preparation include:

=== Virus shedding in airways of non-natural hosts === Sendai virus administration to non-natural hosts results in shedding virions in the airways. Thus, 10 hours later after intranasal SeV administration, infectious virions carrying foreign trans genes can be detected in sheep's' lungs. Moreover, SeV replicates to detectable levels in the upper and lower respiratory tract of African green monkeys and chimpanzees.

== History == The sucrose hemolysis test was developed in the 1960s. Hartmann and Jenkins first described the test in 1966. The test was devised as a superior screen for PNH compared to the Ham's acid hemolysis test (HT) that was developed in the 1930s. For decades, these two tests were the primary methods of diagnosing PNH. The test is now obsolete being replaced by more advanced methods such as flow cytometry with monoclonal antibodies CD55/CD59 that target glycosylphosphatidylinositol-anchored proteins (GPI-AP) with the addition of inactivated fluorescently labeled bacterial toxins, such as fluorescently labeled aerolysin (FLAER). Flow cytometry is the most sensitive and useful assay currently available to screen and diagnosis PNH.

Sources: en.wikipedia.org

Reference notes

In a flowing plasma afterglow, ions are formed in a flow of inert gas, typically helium or argon. Reagents are added downstream to create ion products and study reaction rates. Flowing-afterglow mass spectrometry is used for trace gas analysis for organic compounds.

Refrigerators 2 to 3 °C (35 to 38 °F), and not greater than maximum refrigerator temperature at 5 °C (41 °F) Freezer, Reach-in −23 to −15 °C (−10 to +5 °F) Freezer, Walk-in −23 to −18 °C (−10 to 0 °F) Freezer, Ice Cream −29 to −23 °C (−20 to −10 °F)

In early 2010, Brigadier General Scott Miller took command of CJSOTF-Afghanistan and assigned virtually all SOF in the theatre to a new counterinsurgency role that would become known as the ALP/VSO Program (Afghan Local Police/Village Stability Operations), the SOF in Afghanistan were organised into battalion level SOTF (Special Operations Task Forces) each with a geographic area of responsibility. 1st SFG would have responsibility for southwestern Afghanistan, other Green Berets would have responsibilities in southern and eastern Afghanistan; In March 2012, Green Beret ODA teams suffered several casualties to Green on Blue attacks. On 13 September 2011 an ODA team from 1st Battalion 10th SFG, partnered with Hungarian Special Operations and Afghan National Police, carried out an operation to apprehend known insurgents in Maiden Shahr District, Wardak Province – an area traditionally used by insurgents to move undetected by opposing coalition forces. The main body of the force patrolled through a village from the north-east, whilst the ODA's team sergeant, MSG Danial Adams, led a small element, which convoyed through the mountainous area on the outskirts of a village via ATVs to provide necessary over watch and to facilitate radio communications from the high ground to the west. After approximately three hours of searching, they were unable to locate their target, so they began to withdraw from the village; it was at that time that they lost their aerial reconnaissance assets, which were pulled away to assist coalition forces in other parts of the country.

=== Intramural and extramural research === In 2019, the NIH devoted 10% of its funding to research within its own facilities (intramural research), and gave >80% of its funding in research grants to extramural (outside) researchers. Of this extramural funding, a certain percentage (2.8% in 2014) must be granted to small businesses under the SBIR/STTR program. As of 2011, the extramural funding consisted of about 50,000 grants to more than 325,000 researchers at more than 3000 institutions. By 2018, this rate of granting remained reasonably steady, at 47,000 grants to 2,700 organizations. In FY 2010, the NIH spent US$10.7bn (not including temporary funding from the American Recovery and Reinvestment Act of 2009) on clinical research, US$7.4bn on genetics-related research, US$6.0bn on prevention research, US$5.8bn on cancer, and US$5.7bn on biotechnology.

Sources: en.wikipedia.org

Notes from published material

Barbituric acid itself does not have any direct effect on the central nervous system and chemists have derived over 2,500 compounds from it that possess pharmacologically active qualities. The broad class of barbiturates is further broken down and classified according to speed of onset and duration of action. Ultrashort-acting barbiturates are commonly used for anesthesia because their extremely short duration of action allows for greater control. These properties allow doctors to rapidly put a patient "under" in emergency surgery situations. Doctors can also bring a patient out of anesthesia just as quickly, should complications arise during surgery. The middle two classes of barbiturates are often combined under the title "short/intermediate-acting." These barbiturates are also employed for anesthetic purposes, and are also sometimes prescribed for anxiety or insomnia. This is not a common practice anymore, however, owing to the dangers of long-term use of barbiturates; they have been replaced by the benzodiazepines and Z-drug such as zolpidem, zaleplon and eszopiclone for sleep. The final class of barbiturates are known as long-acting barbiturates (the most notable one being phenobarbital, which has a half-life of roughly 92 hours). This class of barbiturates is used almost exclusively as anticonvulsants, although on rare occasions they are prescribed for daytime sedation. Barbiturates in this class are not used for insomnia, because, owing to their extremely long half-life, patients would awake with a residual "hang-over" effect and feel groggy.

Legislative houses in each political entity are the main source of law in Brazil. The National Congress is the federation's bicameral legislature, consisting of the Chamber of Deputies and the Federal Senate. The Senate represents the 26 states and the Federal District. Each state and the Federal District has a representation of three senators, who are elected by popular ballot for a term of eight years. The Chamber of Deputies represents the people of each state, and its members are elected for a four-year term by a system of proportional representation. Judiciary authorities exercise jurisdictional duties almost exclusively. According to International IDEA's Global State of Democracy (GSoD) Indices and Democracy Tracker, Brazil performs in the mid to high range on overall democratic measures, with particular strengths in inclusive suffrage, freedom of religion, and civic engagement. In 2021, the Economist Intelligence Unit's Democracy Index categorized Brazil as a "flawed democracy", ranking 46th in the report, and Freedom House classified it as a free country at Freedom in the World report. According to the Regimes of the World classification Brazil was an electoral democracy in year 2024. The political-administrative organization of the Federative Republic of Brazil comprises the Union, the states, the Federal District, and the municipalities. The Union, the states, the Federal District, and the municipalities, are the "spheres of government".

Orlistat is a lipase inhibitor which prevents the absorption of fats after meals. It is approved in children 12 years and older, but use is often limited due to adverse reactions of bowel urgency, fecal incontinence, flatulence and it may cause deficiencies in fat-soluble vitamins. Phentermine is an amphetamine analogue which is used as an appetite suppressant; it may be used for up to 12 weeks at a time in adolescents 16 years and older. Possible adverse reactions include headache, nausea, palpitations, elevations in blood pressure, restlessness or insomnia. Phentermine is also available in combination with topiramate extended release and the combination is approved for use in adolescents 12 years and older. Topiramate is an anticonvulsant, but has been shown to cause weight loss. Phentermine-topiramate XR has similar possible side effects to phentermine and users should be on contraception due to the risk of teratogenic effects of the medication. Liraglutide and semaglutide are glucagon-like peptide-1 receptor agonists which are approved for the treatment of obesity in adolescents 12 years and older. Liraglutide is a once-daily injection and semaglutide is a once-weekly injection. They are thought to work by delaying gastric emptying, decreasing appetite and increasing satiety. Possible side effects of liraglutide or semaglutide include gastrointestinal distress including nausea, vomiting, diarrhea or constipation, abdominal discomfort or indigestion.

Sources: en.wikipedia.org

Frequently asked questions

How does the reactive group attach to albumin?

A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.

Does the modification change how the peptide signals?

The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.

Are human half-life figures well established?

Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.

Which receptor does the compound target?

It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.

Network